A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
Status:
Recruiting
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this two-part study is to evaluate the safety and efficacy of the study
drug known as LY2880070 in participants with advanced or metastatic solid tumors.